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8Aim and outline of 
this thesis
Aim of the study
There is compelling evidence that colorectal carcinoma (CRC) has a benign requisite 
precursor, the colorectal polyp (in most cases an adenoma). One to two percent of all 
CRC patients have a genetic predisposition for multiple polyps, called polyposis. Two 
main responsible genes have been identified: i.e. APC in 1991 and MUTYH in 2002. 
Further elucidation of the clinical spectrum of heritable CRC and polyposis syndromes 
is relevant for estimating cancer risks, simplifying the diagnostic route and offering 
reliable tailor made surveillance. This thesis describes several clinical and molecular 
aspects of MUTYH-associated polyposis (MAP). MAP is found in up to a quarter of 
polyposis patients. In addition we aimed for the detection of less well known mutations 
in the APC gene in patients previously reported APC negative. 
Outline of the thesis
I Introduction
In chapter 1 an introduction on polyposis/CRC syndromes and an update on the latest 
research on MUTYH-associated polyposis are given. 
•	 1.1 General introduction on polyposis syndromes.
•	 1.2 Update on MUTYH-associated polyposis.
II Clinical phenotype of MAP
In chapter 2 the clinical phenotype of MAP in biallelic MUTYH carriers is presented, 
including the spectrum of extracolonic manifestations and genotype-phenotype 
correlations. Furthermore, the prevalence of MUTYH and APC mutations in well defined 
attenuated familial adenomatous polyposis (AFAP) families is determined.
•	 2.1 Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients 
with MUTYH-associated polyposis coli (MAP). 
•	 2.2 Duodenal carcinoma in MUTYH-associated polyposis.
•	 2.3 Expanded extracolonic tumour spectrum in MUTYH-associated polyposis.
hoofdstuk 0_aim and outline.indd   8 26-1-11   15:46
Aim and outline of this thesis
9
•	 2.4 Analysis of MUTYH genotypes and colorectal phenotypes in patients with 
MUTYH-associated polyposis. 
•	 2.5 Germline mutations in APC and MUTYH are responsible for the majority of 
families with attenuated familial adenomatous polyposis. 
 
III MUTYH heterozygotes
There has been much debate on the possible risk to develop CRC for carriers of a 
single MUTYH mutation. Because of the high prevalence of MUTYH heterozygotes 
in the population (1-2%), an estimation of a possible elevated CRC risk is of clinical 
importance. Most studies estimating odds ratios are population based case and control 
studies. Another approach, namely family based, is presented in chapter 3. Also, the 
significant prevalence of MUTYH heterozygotes in the population has implications for 
the offspring of MAP patients. MAP can be transmitted to the next generation when the 
spouse of a MAP patient happens to be a MUTYH heterozygote. In paragraph 2 a cost 
effectiveness study is presented determining whether partner screening for MUTYH is 
cost effective.
•	 3.1 Increased colorectal cancer incidence in obligate carriers of heterozygous 
mutations in MUTYH.
•	 3.2 Cost-utility analysis of genetic screening in families of patients with germline 
MUTYH mutations. 
IV Pathology and tumour studies in MAP patients
The underlying genetic defect in MAP syndrome and Lynch syndrome, the most common 
inheritable CRC syndrome, both affect the DNA–repair system. Given the specific 
histology and molecular hallmarks in Lynch associated CRCs, the pathologist has an 
important role in identifying Lynch patients. So far, little pathognomonic features have 
been described for MAP CRCs. In chapter 4 the molecular and histopathology aspects 
of MAP CRCs are analyzed and compared with sporadic, MSI-high and Lynch syndrome 
CRCs (paragraph 1). Also the genetic instability involved in the MAP carcinogenesis is 
studied (paragraph 2). Furthermore the feasibility of identifying MAP patients with less 
florid polyposis by KRAS2 c.34G>T prescreening followed by MUTYH hotspot mutation 
analysis in formalin-fixed paraffin-embedded tissue (FFPE) is studied (paragraph 3).
Specific histological and molecular genetic features in MAP CRCs might influence 
tumour behaviour and survival. In theory, the disruption of the MUTYH function in MAP 
carcinomas might lead to a surplus of mutated peptides that activate the immune system 
and would thereby lead to a better survival of MAP than sporadic CRC cases. Because 
of the activated immune system a strong selective pressure can be expected, favouring 
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the outgrowth of tumour cell clones with an immune evasive phenotype. Defects in the 
human leukocyte antigen (HLA) class I expression are a well known mechanism for 
avoiding cancer cell recognition and thus immune evasion in colorectal cancers bearing 
mismatch repair (MMR) deficiencies. It was hypothesized that these HLA class 1 defects 
might also occur in MAP carcinomas. Paragraph 4 and 5 show the results of a survival 
study in a European MAP patient’s cohort and a study on the HLA class I expression in 
MAP carcinomas.
•	 4.1 Colorectal carcinomas in MUTYH-associated polyposis display histopathological 
similarities to microsatellite unstable carcinomas. 
•	 4.2 High frequency of copy-neutral LOH in MUTYH-associated polyposis 
carcinomas. 
•	 4.3 Identification of patients with (atypical) MUTYH-associated polyposis by 
KRAS2 c.34G>T pre-screening followed by MUTYH hotspot analysis in formalin-
fixed paraffin-embedded tissue. 
•	 4.4 Survival of MUTYH-Associated Polyposis Patients With Colorectal Cancer and 
Matched Control Colorectal Cancer Patients. 
•	 4.5 MUTYH-associated polyposis carcinomas frequently lose HLA class I 
expression-a common event amongst DNA-repair-deficient colorectal cancers.  
V Other causes of polyposis
A branch of a Lynch (HNPCC) family in which MSH6 and MUTYH germline mutations co-
segregate is studied in chapter 5, paragraph 1. This family demonstrates the clinical 
consequences of different combinations of base excision repair and mismatch repair 
defects.
In a number of polyposis patients the genetic predisposition remains to be elucidated. 
In paragraph 2 it is analysed whether enzymes working together with MUTYH in 
protecting the DNA against oxidative damage (like OGG1, NUDT1, NTH1, NEIL1, 2 and 
3) represent candidate polyposis genes. In paragraph 3 Multiplex Ligation-dependent 
Probe Amplification (MLPA) is used to detect previously unnoticed deletions in the APC 
gene and in paragraph 4 the prevalence of somatic mosaism of APC gene mutations is 
studied. We shown that APC gene deletions (paragraph 2) and mosaic APC mutations 
(paragraph 3) explain a tangible proportion of the so far unaccounted for polyposis 
patients.
•	 5.1 The natural history of a combined defect in MSH6 and MUTYH in a Dutch 
HNPCC family.
•	 5.2 Inherited predisposition to colorectal adenomas caused by multiple rare alleles 
of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3. 
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•	 5.3 APC Genotype-phenotype correlations in 19 Dutch cases with APC gene 
deletions and a literature review. 
•	 5.4 Somatic APC Mosaicism: An Underestimated Cause of Polyposis Coli. 
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